Regulation of human tissue kallikrein-related peptidase expression by steroid hormones in 32 cell lines

Biological Chemistry

Volumn 389, Issue 11, 2008, Pages 1409-1419

  Shaw, Julie L V ^a,b   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer biomarkers; Cell lines; Gene regulation; Kallikrein related peptidases; Serine proteases; Steroid hormones

Indexed keywords

ANDROSTANOLONE; BIOLOGICAL MARKER; DEXAMETHASONE; ESTRADIOL; HUMAN TISSUE KALLIKREIN RELATED PEPTIDASE; KALLIKREIN 10; KALLIKREIN 11; KALLIKREIN 13; KALLIKREIN 3; KALLIKREIN 5; KALLIKREIN 6; KALLIKREIN 7; NEUROPSIN; NORGESTREL; PEPTIDASE; SERINE PROTEINASE; STEROID HORMONE; TISSUE KALLIKREIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL LINE; CELL STIMULATION; COLON CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HORMONAL REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; LUNG CANCER; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SUPERNATANT; T LYMPHOCYTE; UPREGULATION; UTERINE CERVIX CANCER;

BASE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HORMONES; HUMANS; STEROIDS; TISSUE KALLIKREINS;

EID: 56549130235     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.158     Document Type: Article

References (50)

1. Adcock, I.M. (2001). Glucocorticoid-regulated transcription factors. Pulm. Pharmacol. Ther. 14, 211-219.
2. Bamberger, A.M., Jenatschke, S., Erdmann, I., and Schulte, H.M. (1997). Progestin-dependent stimulation of the human leukemia inhibitory factor promoter in SKUT-1B uterine tumor cells. J. Reprod. Immunol. 33, 189-201.
3. Berman, E., Adams, M., Duigou-Osterndorf, R., Godfrey, L., Clarkson, B., and Andreeff, M. (1991). Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. Blood 77, 818-825.
4. Bernett, M.J., Blaber, S.I., Scarisbrick, I.A., Dhanarajan, P., Thompson, S.M., and Blaber, M. (2002). Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562-24570.
5. Blaber, S.I., Scarisbrick, I.A., Bernett, M.J., Dhanarajan, P., Seavy, M.A., Jin, Y., Schwartz, M.A., Rodriguez, M., and Blaber, M. (2002). Enzymatic properties of rat myelencephalon-specific protease. Biochemistry 41, 1165-1173.
6. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
7. Borgono, C.A., Michael, I.P., and Diamandis, E.P. (2004). Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2, 257-280.
8. Borgono, C.A., Michael, I.P., Komatsu, N., Jayakumar, A., Kapadia, R., Clayman, G.L., Sotiropoulou, G., and Diamandis, E.P. (2007). A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J. Biol. Chem. 282, 3640-3652.
9. Castagnetta, L., Carruba, G., Granata, O.M., Lo, C.M., Arcuri, F., Mesiti, M., and Pavone-Macaluso, M. (1990). Prostate long-term epithelial cell lines. Biological and biochemical features. Ann. NY Acad. Sci. 595, 149-164.
10. Caubet, C., Jonca, N., Brattsand, M., Guerrin, M., Bernard, D., Schmidt, R., Egelrud, T., Simon, M., and Serre, G. (2004). Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122, 1235-1244.
11. Clarkson, R.W., Boland, M.P., Kritikou, E.A., Lee, J.M., Freeman, T.C., Tiffen, P.G., and Watson, C.J. (2006). The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol. Endocrinol. 20, 675-685.
12. Corbishley, T.P., Iqbal, M.J., Wilkinson, M.L., and Williams, R. (1986). Androgen receptor in human normal and malignant pancreatic tissue and cell lines. Cancer 57, 1992-1995.
13. Diamandis, E.P., Yousef, G.M., Soosaipillai, A.R., and Bunting, P. (2000). Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin. Biochem. 33, 579-583.
14. Ding, J.X., Feng, Y.J., Yao, L.Q., Yu, M., Jin, H.Y., and Yin, L.H. (2006). The reinforcement of invasion in epithelial ovarian cancer cells by 17 β-Estradiol is associated with up-regulation of Snail. Gynecol. Oncol. 103, 623-630.
15. Duma, D., Jewell, C.M., and Cidlowski, J.A. (2006). Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 102, 11-21.
16. Engel, L.W. and Young, N.A. (1978). Human breast carcinoma cells in continuous culture: a review. Cancer Res. 38, 4327-4339.
17. Ghosh, M.C., Grass, L., Soosaipillai, A., Sotiropoulou, G., and Diamandis, E.P. (2004). Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 25, 193-199.
18. Hall, R.E., Lee, C.S., Alexander, I.E., Shine, J., Clarke, C.L., and Sutherland, R.L. (1990). Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int. J. Cancer 46, 1081-1087.
19. Hartel, A., Didier, A., Ulbrich, S.E., Wierer, M., and Meyer, H.H. (2004). Characterisation of steroid receptor expression in the human prostate carcinoma cell line 22RV1 and quantification of androgen effects on mRNA regulation of prostate-specific genes. J. Steroid Biochem. Mol. Biol. 92, 187-197.
20. Henttu, P., Liao, S.S., and Vihko, P. (1992). Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130, 766-772.
21. Johnson, S.K., Ramani, V.C., Hennings, L., and Haun, R.S. (2007). Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 109, 1811-1820.
22. Jones, J., Lagasse, L.D., and Karlan, B.Y. (1994). Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines. Gynecol. Oncol. 55, 421-426.
23. Kapadia, C., Ghosh, M.C., Grass, L., and Diamandis, E.P. (2004). Human kallikrein 13 involvement in extracellular matrix degradation. Biochem. Biophys. Res. Commun. 323, 1084-1090.
24. Kishi, T., Grass, L., Soosaipillai, A., Shimizu-Okabe, C., and Diamandis, E.P. (2003). Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin. Chem. 49, 87-96.
25. Kulasingam, V. and Diamandis, E.P. (2007). Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines. Biol. Chem. 388, 1113-1119.
26. Lu, N.Z. and Cidlowski, J.A. (2006). Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol. 16, 301-307.
27. Luo, L.Y., Katsaros, D., Scorilas, A., Fracchioli, S., Bellino, R., van Gramberen, M., de Bruijn, H., Henrik, A., Stenman, U.H., Massobrio, M., et al. (2003). The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res. 63, 807-811.
28. Macinga, D., Jain, V., Sizemore, N., Gorodeski, G.I., Eckert, R.L., and Rorke, E.A. (1995). Tamoxifen regulation of ectocervical cell differentiation. J. Soc. Gynecol. Invest. 2, 754-761.
29. Magklara, A., Grass, L., and Diamandis, E.P. (2000). Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines. Breast Cancer Res. Treat. 59, 263-270.
30. Michael, I.P., Sotiropoulou, G., Pampalakis, G., Magklara, A., Ghosh, M., Wasney, G., and Diamandis, E.P. (2005). Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J. Biol. Chem. 280, 14628-14635.
31. Michael, I.P., Pampalakis, G., Mikolajczyk, S.D., Malm, J., Sotiropoulou, G., and Diamandis, E.P. (2006). Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. J. Biol. Chem. 281, 12743-12750.
32. Obiezu, C.V., Michael, I.P., Levesque, M.A., and Diamandis, E.P. (2006). Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins. Biol. Chem. 387, 749-759.
33. Onda, K., Nagashima, M., Kawakubo, Y., Inoue, S., Hirano, T., and Oka, K. (2006). Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNFa in human epidermal keratinocytes (HaCaT). Biochem. Biophys. Res. Commun. 351, 266-272.
34. Paliouras, M. and Diamandis, E.P. (2007). Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res. Treat. 102, 7-18.
35. Pellegrini, S. and Dusanter-Fourt, I. (1997). The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248, 615-633.
36. Petraki, C.D., Karavana, V.N., Revelos, K.I., Luo, L.Y., and Diamandis, E.P. (2002). Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets. Histochem. J. 34, 313-322.
37. Pilat, M.J., Christman, J.K., and Brooks, S.C. (1996). Characterization of the estrogen receptor transfected MCF10A breast cell line 139B61. Breast Cancer Res. Treat. 37, 253-266.
38. Planas-Silva, M.D., Donaher, J.L., and Weinberg, R.A. (1999). Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression. Cancer Res. 59, 4788-4792.
39. Rajapakse, S., Ogiwara, K., Takano, N., Moriyama, A., and Takahashi, T. (2005). Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett. 579, 6879-6884.
40. Ruutu, M., Wahlroos, N., Syrjanen, K., Johansson, B., and Syrjanen, S. (2006). Effects of 17β-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines. Int. J. Gynecol. Cancer 16, 1261-1268.
41. Sager, G., Orbo, A., Jaeger, R., and Engstrom, C. (2003). Nongenomic effects of progestins - inhibition of cell growth and increased intracellular levels of cyclic nucleotides. J. Steroid Biochem. Mol. Biol. 84, 1-8.
42. Sasaki, M., Tanaka, Y., Perinchery, G., Dharia, A., Kotcherguina, I., Fujimoto, S., and Dahiya, R. (2002). Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J. Natl. Cancer Inst. 94, 384-390.
43. Scarisbrick, I.A., Blaber, S.I., Tingling, J.T., Rodriguez, M., Blaber, M., and Christophi, G.P. (2006a). Potential scope of action of tissue kallikreins in CNS immune-mediated disease. J. Neuroimmunol. 178, 167-176.
44. Scarisbrick, I.A., Sabharwal, P., Cruz, H., Larsen, N., Vandell, A.G., Blaber, S.I., Ameenuddin, S., Papke, L.M., Fehlings, M.G., Reeves, R.K., et al. (2006b). Dynamic role of kallikrein 6 in traumatic spinal cord injury. Eur. J. Neurosci. 24, 1457-1469.
45. Schoneveld, O.J., Gaemers, I.C., and Lamers, W.H. (2004). Mechanisms of glucocorticoid signalling. Biochim. Biophys. Acta 1680, 114-128.
46. Shaw, J.L. and Diamandis, E.P. (2007). Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423-1432.
47. Somasekhar, M.B. and Gorski, J. (1988). An estrogen-responsive element from the 59-flanking region of the rat prolactin gene functions in MCF-7 but not in HeLa cells. Gene 69, 23-28.
48. Stamey, T.A., Yang, N., Hay, A.R., McNeal, J.E., Freiha, F.S., and Redwine, E. (1987). Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317, 909-916.
49. Veveris-Lowe, T.L., Lawrence, M.G., Collard, R.L., Bui, L., Herington, A.C., Nicol, D.L., and Clements, J.A. (2005). Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelialmesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr. Relat. Cancer 12, 631-643.
50. Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184-204.